Based on recent data, X4 Pharmaceuticals, Inc. (XFOR) shows an Average True Range (ATR) of 0.23 and an Enterprise Value of 175.46M. Its average trading volume over the past 3 months is 396.14K, indicating liquidity. These fundamental metrics provide insight into XFOR's underlying financial health and market activity.
| ATR | 0.23 |
| Enterprise Value | 175.46M |
| Avg Vol (3 Months) | 396.14K |
| Avg Vol (10 Days) | 542.09K |
X4 Pharmaceuticals, Inc. (XFOR) technical indicators as of June 23, 2026: the SMA 20 is -6.47%, SMA 50 at -12.52%, and SMA 200 at 1.61%. The RSI 14 value is 42.39, suggesting its current momentum. These technical analysis signals help assess XFOR's price trends and potential future movements.
| SMA 20 | -6.47% |
| SMA 50 | -12.52% |
| SMA 200 | 1.61% |
| RSI 14 | 42.39 |
X4 Pharmaceuticals, Inc. (XFOR) stock performance overview as of June 23, 2026: The 52-week high is $4.83 (currently -75.98% below), and the 52-week low is $1.35 (currently 140.74% above). Over the past year, XFOR's performance is -73.47%, compared to the S&P 500's 10.67% change.
| 52-Week High | 4.83 |
| 52-Week High Chg | -75.98% |
| 52-Week Low | 1.35 |
| 52-Week Low Chg | +140.74% |
| S&P 500 52-Week Chg | 10.67% |
According to market data, X4 Pharmaceuticals, Inc. (XFOR) stock's recent performance metrics show that over the last month, XFOR is 4.56%, with a Year-to-Date (YTD) performance of -8.25%. Over the past year, the stock has seen a -73.47% change. These figures summarize XFOR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 4.43 | 4.43 | 4.66 | 4.83 | 4.83 | 4.83 |
| Low | 3.99 | 3.58 | 3.53 | 2.83 | 1.35 | 2.83 |
| Performance | -5.90% | +4.56% | +23.57% | +139.87% | -73.47% | -8.25% |
According to current financial data, XFOR stock's P/E (TTM) ratio is -0.94, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for XFOR, including P/S (44.89), P/B (3.22), and P/FCF (-5.52), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | XFOR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.94 | -1.22 | -5.02 | 32.59 |
| P/S (TTM) | 44.89 | 3.69 | 462.04 | 5.98 |
| P/B (TTM) | 3.22 | 1.23 | 12.18 | 5 |
| P/FCF (TTM) | -5.52 | -3.34 | -908.56 | 28.32 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep